
Breakthrough with new interventional treatment technology
Preliminary data from the clinical study showed that the dose reduction achieved in the X-ray guided endovascular procedures performed on 50 patients using Philips’ ClarityIQ technology is in line with the expected X-ray dose reduction of 75%.
























